Cargando…
Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction?
Introduction: Tamoxifen is associated with a twofold increased risk of thromboembolic events. Third generation aromatase inhibitors (AIs), such as letrozole, anastrozole, and exemestane have therefore replaced tamoxifen in the adjuvant therapy of hormone receptor-positive breast cancer. A retrospect...
Autores principales: | Jokuszies, Andreas, Radtke, Christine, Betzler, Christopher, Branski, Ludwik, Krämer, Robert, Vogt, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575563/ https://www.ncbi.nlm.nih.gov/pubmed/23423877 http://dx.doi.org/10.3205/000173 |
Ejemplares similares
-
How to become a medical professor – a comparative analysis of academic requirements in Germany and the United States
por: Alawi, Seyed Arash, et al.
Publicado: (2019) -
Anticoagulative strategies in reconstructive surgery – clinical significance and applicability
por: Jokuszies, Andreas, et al.
Publicado: (2012) -
Quality of life and reconstructive surgery efforts in severe hand injuries
por: Alawi, Seyed Arash, et al.
Publicado: (2018) -
Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis
por: Eggemann, Holm, et al.
Publicado: (2019) -
Autologous Microvascular Breast Reconstruction
por: Healy, Claragh, et al.
Publicado: (2013)